首页|宫颈脱落细胞FAM19A4/miR124-2甲基化在绝经后HR-HPV感染患者中的表达情况分析

宫颈脱落细胞FAM19A4/miR124-2甲基化在绝经后HR-HPV感染患者中的表达情况分析

扫码查看
目的 探究宫颈脱落细胞FAM19A4/miR124-2 甲基化在绝经后高危型人乳头瘤病毒(HR-HPV)感染患者中的表达情况.方法 回顾性选取 120 例绝经后HR-HPV感染患者为观察组,另选取120 例绝经后无人乳头瘤病毒(HPV)感染者为对照组.比较两组的宫颈脱落细胞FAM19A4/miR124-2甲基化检出率及辅助性T细胞 17(Th17)类细胞因子[白细胞介素(IL)-17、IL-22]水平;比较观察组不同病理结果及低度鳞状上皮内病变(LSIL)不同临床转归情况患者的宫颈脱落细胞FAM19A4/miR124-2甲基化检出率、Th17 类细胞因子水平.结果 观察组的宫颈脱落细胞FAM19A4/miR124-2 甲基化检出率及IL-17、IL-22水平分别为38.33%、(89.21±20.06)pg/ml、(44.91±9.13)pg/ml,显著高于对照组的1.67%、(22.23±6.63)pg/ml、(20.32±5.19)pg/ml,差异有统计学意义(P<0.05).观察组不同病理结果患者的宫颈脱落细胞FAM19A4/miR124-2 甲基化检出率及IL-17、IL-22 水平比较,差异有统计学意义(P<0.05).观察组高度鳞状上皮内病变(HSIL)患者的宫颈脱落细胞FAM19A4/miR124-2 甲基化检出率及IL-17、IL-22 水平高于宫颈炎及LSIL患者,且LSIL患者高于宫颈炎患者,差异有统计学意义(P<0.05).观察组LSIL不同转归情况患者的宫颈脱落细胞FAM19A4/miR124-2 甲基化检出率及IL-17、IL-22 水平比较,差异有统计学意义(P<0.05).观察组LSIL进展患者的宫颈脱落细胞FAM19A4/miR124-2 甲基化检出率及IL-17、IL-22 水平高于消退及持续患者,且LSIL持续患者高于LSIL消退患者,差异有统计学意义(P<0.05).结论 宫颈脱落细胞FAM19A4/miR124-2 甲基化检出率在绝经后HR-HPV感染患者中相对更高,且不同病理结果及LSIL不同临床转归情况患者的差异显著.
Expression of cervical exfoliated cells FAM19A4/miR124-2 methylation in postmenopausal patients with HR-HPV infection
Objective To investigate the expression of cervical exfoliated cells FAM19A4/miR124-2 methylation in postmenopausal patients with high-risk human papilloma virus(HR-HPV)infection.Methods 120 postmenopausal patients with HR-HPV infection were retrospectively selected as the observation group,and another 120 postmenopausal patients without human papilloma virus(HPV)infection as the control group.Comparison was made on detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation and the levels of T helper cytokines 17(Th17)[interleukin(IL)-17,IL-22]between the two groups,as well as detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation and the Th17 cytokines levels of patients with different pathological results and different clinical regression of low-grade squamous intraepithelial lesions(LSIL)in the observation group.Results In the observation group,the detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation and the levels of IL-17 and IL-22 were 38.33%,(89.21±20.06)pg/ml,and(44.91±9.13)pg/ml,which were significantly higher than 1.67%,(22.23±6.63)pg/ml,and(20.32±5.19)pg/ml in the control group.The difference was statistically significant(P<0.05).The detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation and the levels of IL-17 and IL-22 of subjects with different pathological findings in the observation group were compared,and the difference was statistically significant(P<0.05).In the observation group,the detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation and the levels of IL-17 and IL-22 in patients with high-grade squamous intraepithelial lesions(HSIL)were higher than those in patients with cervicitis and LSIL,and the above indicators in patients with LSIL were higher than those in patients with cervicitis.The difference was statistically significant(P<0.05).The detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation and the levels of IL-17 and IL-22 of patients with different LSIL regression in the observation group were statistically significant(P<0.05).In the observation group,the detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation and the levels of IL-17 and IL-22 of patients with LSIL progression were higher than those of patients with remission and persistence,and patients with persistence of LSIL had higher indicators than those with remission of LSIL.The difference was statistically significant(P<0.05).Conclusion The detection rate of cervical exfoliated cells FAM19A4/miR124-2 methylation is relatively high in postmenopausal patients with HR-HPV infection,and differences of patients with different pathological results and different clinical regression of patients with LSIL are significant.

Cervical exfoliated cellsFAM19A4/miR124-2MenopauseHigh-risk human papillomavirus infection

张欣宁、吴海燕、朱伟艳、刘永珠、何晓婷、郑艳红

展开 >

511500 清远市人民医院

宫颈脱落细胞 FAM19A4/miR124-2 绝经 高危型人乳头瘤病毒感染

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(10)